Concepedia

Klaus Vosbeck

KV

Statistics

Publications

16

Citations

1.2K

H-Index

15

Active since

1973

Affiliations

Novartis (Switzerland)(Current)

Scripps Clinic

Scripps Health

University of Basel

Klaus Vosbeck is an author at Novartis (Switzerland) specializing in medicine, immunology, and cell signaling.

Top concepts

Publications per year

1973–1995

16

Publications

16

Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cells

Josef Pfeilschifter, W. Pignat, Klaus Vosbeck et al. · Biochemical and Biophysical Research Communications · 1989 · 191 citations

, , +15

Hydrogen peroxide as a potent bacteriostatic antibiotic: Implications for host defense

Paul A. Hyslop, Daniel B. Hinshaw, Ingrid U. Scraufstatter et al. · Free Radical Biology and Medicine · 1995 · 185 citations

, , +11

Transforming growth factor β2 inhibits interleukin 1β- and tumour necrosis factor α-induction of nitric oxide synthase in rat renal mesangial cells

Josef Pfeilschifter, Klaus Vosbeck · Biochemical and Biophysical Research Communications · 1991 · 162 citations

, , +14

Priming of Polymorphonuclear Granulocytes by Lipopolysaccharides and Its Complexes With Lipopolysaccharide Binding Protein and High Density Lipoprotein

Klaus Vosbeck, Peter S. Tobias, Heinz Mueller et al. · Journal of Leukocyte Biology · 1990 · 129 citations

Interleukin 1β and tumour necrosis factor α induce a macrophage‐type of nitric oxide synthase in rat renal mesangial cells

Josef Pfeilschifter, Peter Rob, Alexander Mülsch et al. · European Journal of Biochemistry · 1992 · 127 citations

1–5 of 16